MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn495791600
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 071115s2008 nyua ob 001 0 eng d
040 |a DKU  |b eng  |e pn  |c DKU  |d OCLCQ  |d E7B  |d OCLCQ  |d FVL  |d OCLCQ  |d OCLCF  |d NLGGC  |d OCLCO  |d IDEBK  |d OCLCQ  |d AZK  |d MOR  |d OCLCO  |d PIFAG  |d OTZ  |d OCLCQ  |d U3W  |d OCLCA  |d STF  |d WRM  |d COCUF  |d NRAMU  |d OCLCQ  |d HS0  |d VLY  |d K6U  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 646750656  |a 722669090  |a 728036191  |a 961537359  |a 962590677  |a 988481055  |a 992030769  |a 994982565  |a 1037901047  |a 1038556140  |a 1045497443  |a 1058590755  |a 1065089094  |a 1097160659  |a 1162255692 
020 |z 9781420053555  |q (v. 2 ;  |q hbk. ;  |q alk. paper) 
020 |z 1420053558  |q (v. 2 ;  |q hbk. ;  |q alk. paper) 
020 |a 0429092865 
020 |a 9780429092862 
020 |a 1420045261 
020 |a 9781420045260 
029 1 |a AU@  |b 000050968479 
029 1 |a AU@  |b 000053024374 
029 1 |a NZ1  |b 13340609 
035 |a (OCoLC)495791600  |z (OCoLC)646750656  |z (OCoLC)722669090  |z (OCoLC)728036191  |z (OCoLC)961537359  |z (OCoLC)962590677  |z (OCoLC)988481055  |z (OCoLC)992030769  |z (OCoLC)994982565  |z (OCoLC)1037901047  |z (OCoLC)1038556140  |z (OCoLC)1045497443  |z (OCoLC)1058590755  |z (OCoLC)1065089094  |z (OCoLC)1097160659  |z (OCoLC)1162255692 
050 4 |a RS201.C64  |b M632 2008eb 
082 4 |a 615/.19 
049 |a UAMI 
245 0 0 |a Modified-release drug delivery technology.  |n Volume 2 /  |c edited by Michael J. Rathbone [and others]. 
250 |a 2nd ed. 
260 |a New York :  |b Informa Healthcare,  |c ©2008. 
300 |a 1 online resource (xv, 696 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Drugs and the pharmaceutical sciences ;  |v 184 
504 |a Includes bibliographical references and indexes. 
588 0 |a Print version record. 
505 0 |a ""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulationâ€?PLAD Technology"" 
505 8 |a ""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" 
505 8 |a ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" 
505 8 |a ""27 LidoSiteâ€?Vyteris Iontophoretic Technology""""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" 
505 8 |a ""37 Phospholipids as Carriers for Vaginal Drug Delivery""""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Controlled release technology. 
650 0 |a Controlled release preparations. 
650 0 |a Drug delivery systems. 
650 0 |a Pharmaceutical technology. 
650 2 |a Delayed-Action Preparations 
650 2 |a Drug Delivery Systems 
650 2 |a Technology, Pharmaceutical 
650 6 |a Effet retard. 
650 6 |a Préparations-retard. 
650 6 |a Systèmes d'administration de médicaments. 
650 6 |a Techniques pharmaceutiques. 
650 7 |a Controlled release preparations  |2 fast 
650 7 |a Controlled release technology  |2 fast 
650 7 |a Drug delivery systems  |2 fast 
650 7 |a Pharmaceutical technology  |2 fast 
700 1 |a Rathbone, Michael J.,  |d 1957-  |1 https://id.oclc.org/worldcat/entity/E39PCjDfJvfXY8CMWyDfvQFxWC 
758 |i has work:  |a Modified-release drug delivery technology Volume 2 (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFwWx6pRtjJjW3GrRvdTgX  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 |z 1-84184-928-6 
776 |z 1-4200-5355-8 
830 0 |a Drugs and the pharmaceutical sciences ;  |v 184. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3059669  |z Texto completo 
938 |a ebrary  |b EBRY  |n ebr10231564 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis18532569 
994 |a 92  |b IZTAP